Turkey Coronary Stents Market Report 2022 to 2030

Turkey Coronary Stents Market Analysis

$ 3999

Turkey's Coronary Stents Market is expected to witness growth from $90 Mn in 2022 to $136 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-30. The demand for coronary stents is anticipated to rise in Turkey as patients and healthcare professionals become more aware of the advantages of coronary stents. Manufacturers who invest in educational programs to spread the word about the advantages of coronary stents may be able to enhance their market share. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Ersamed Medikal, Acibadem Labmed, Megasan Medikal, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.

ID: IN10TRMD006 CATEGORY: Medical Devices GEOGRAPHY: Turkey AUTHOR: Jigyasu Bhandari

Buy Now

Turkey Coronary Stents Healthcare Market Executive Analysis

Turkey's Coronary Stents Market is expected to witness growth from $90 Mn in 2022 to $136 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-30. Turkish healthcare expenditures totaled $13.7 billion in 2020, a 24.3% increase over 2019. The total amount spent on health increased by 26.3% to $10.48 billion. Spending on healthcare in the private sector was anticipated to reach $2.70 billion, an increase of 17.3%. In contrast to the private sector, which accounted for 20.8% of health expenditures in 2020, the federal government accounted for 79.2% of them.

In Turkey, 196,988 people passed away from heart disease in 2022, making up 19.1% of all fatalities there. Coronary artery disease was present in 6.4% of the overall population. Men (8.1%) had a larger prevalence than women (4.7%). In Turkey, there were 13.8 cases of acute coronary syndrome per 10,000 persons each year, which includes unstable angina and heart attacks. Coronary stents are tiny mesh tubes that are inserted inside constricting or obstructed coronary arteries to maintain their openness and enhance blood flow to the heart muscle. In Turkey, coronary stent usage is a frequent surgery and has revolutionized the way coronary artery disease is treated. By widening or unblocking restricted arteries, coronary stents are generally used to treat coronary artery disease and restore blood flow to the heart muscle. Coronary stents can frequently be used as a substitute for open heart surgery, which can be more invasive and necessitate a longer recovery period. Re-narrowing of the treated artery, or restenosis, is a frequent issue following angioplasty without a stent. Through the provision of a scaffold to keep the artery open, coronary stents assist in lowering the risk of restenosis.

Turkey Coronary Stents Market Analysis

Market Dynamics

Market Growth Drivers

The demand for coronary stents is anticipated to rise in Turkey as patients and healthcare professionals become more aware of the advantages of coronary stents. Manufacturers who make an investment in educational programmes to spread the word about the advantages of coronary stents may be able to enhance their market share. Turkey's ageing population, poor diets, and sedentary lifestyles are all contributing to an increase in the prevalence of coronary heart disease. The demand for coronary stents as a therapeutic option is anticipated to increase as a result, providing potential prospects for manufacturers. The coronary stent market is anticipated to rise as a result of advancements in stent technology, including the creation of drug-eluting stents, bioresorbable stents, and other novel designs. Manufacturers who spend money on research and development to create cutting-edge stent technology will be in a good position to profit from this expansion.

Market Restraints

In Turkey, coronary stents are typically safe and effective, complications and negative outcomes like stent thrombosis, restenosis, and bleeding can still happen. The demand for coronary stents may decline as a result of these issues. The market for coronary stents in Turkey is quite competitive, with many well-known companies vying for market share. It could be challenging for new manufacturers to compete with established companies, which might have an influence on growth. Coronary stents must adhere to strict regulatory standards set by the Turkish government. Before their products may be advertised and sold, manufacturers must adhere to tight laws and receive regulatory authority. This can be a time-consuming and expensive process, which might prevent certain enterprises from expanding.

Competitive Landscape

Key Players

Ersamed Medikal (TR)
Acibadem Labmed (TR)
Megasan Medikal (TR)
Biotronik
Boston Scientific
B. Braun
Abbott Laboratories
GE Healthcare
Medtronic
Philipps Healthcare

Healthcare Policies and Regulatory Landscape

Turkish Ministry of Health (MoH) rules regarding coronary stents. A regulatory framework that has been established by the MoH includes pre-market evaluation, product registration, and post-market monitoring. Before their goods can be advertised and sold in Turkey, producers must abide by certain rules. Through the General Health Insurance system, the Turkish government pays for a number of medical procedures, including coronary stent procedures. The type of stent and the patient's condition, however, may affect reimbursement regulations. To make sure that their products are covered, manufacturers must be aware of reimbursement guidelines and coordinate with healthcare professionals. The National Health Transformation Programme (NHTP) is a thorough healthcare reform initiative with the goal of raising the standard of medical care in Turkey. The programme comprises activities to advance preventive care, broaden access to healthcare services, and enhance healthcare infrastructure. Manufacturers who match the objectives of their products with the NHTP may be in a good position to benefit from expansion opportunities.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Coronary Stents Market Segmentation

By Type (Revenue, USD Billion):

The three main categories of coronary stents are bare-metal, drug-eluting, and bioabsorbable, depending on their nature. The segment for bioabsorbable stents is anticipated to increase at the fastest rate over the forecast period. The benefits that are encouraging the use of bioabsorbable stents include a decrease in problems including thrombosis and inflammation, the cTurkeyity to restore normal vasomotion, and an improvement in aberrant endothelial function. However, in the upcoming years, the expansion of this market segment is anticipated to be constrained by the high cost of bioabsorbable stents.

Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents

By Mode of Delivery (Revenue, USD Billion):

The market is divided into self-expanding and balloon-expandable stents according to delivery method. Because of the high use of these stents, rising research initiatives to advance the technology, and rising regulatory approvals for balloon-expandable stents, the balloon expandable stents segment is anticipated to increase at the greatest CAGR over the projection period.

Balloon-expandable Stents
Self-expanding Stents

By Materials (Revenue, USD Billion):

The coronary stent market is divided into metallic (cobalt chromium, platinum chromium, nickel-titanium, and stainless steel) and other stents according to the material. The market for other stents is anticipated to experience the largest CAGR growth during the projection period. The rapid expansion of this market can be ascribed to the increased use of polymers and copolymers in the production of bioabsorbable stents.

Metallic Stents
Cobalt-Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Other Stents

By End User (Revenue, USD Billion):

The coronary stent market is divided into hospitals, cardiac centres, and ambulatory surgical centres based on the end user. According to predictions, the hospital sector will control the market in 2016. This is primarily caused by hospitals using a lot of coronary stents.

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.